IRRAS Wins Regulatory Approval of IRRAflow® in Israel and Costa Rica |
| June 25, 2019 | June 2019 Bond Updates |
|
STOCKHOLM, June 25, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received regulatory approval for its flagship product, ... |
| View more at: https://www.prnewswire.com:443/news-releases/irras-wins-regulatory-approval-of-irraflow-in-israel-and-costa-rica-300874054.html |
| Related News |
|